Corrigendum to "One or two doses of live varicella virus-containing vaccines: Efficacy, persistence of immune responses, and safety six years after administration in healthy children during their second year of life" [Vaccine 36 (2018) 381-387]

Affiliations

¹ Vaccine Discovery and Development, GSK, Philadelphia, United States. Electronic address: ouzama.n.henry@gsk.com.
² Poradnia Chorób Zakaźnych ZOZ Dębica, Dębica, Poland. Electronic address: jerzy_br@poczta.onet.pl.
³ Infectious Diseases Outpatient Clinic, The St. Luis Provincial Specialist Children's Hospital, Cracow, Poland. Electronic address: hanna.czajka@onet.pl.
⁴ Pediatric Clinic, Lithuanian University of Health Sciences, Kaunas, Lithuania. Electronic address: giedralev@gmail.com.
⁵ Pharmacology, Saratov Medical University, Saratov, Russia. Electronic address: reshetko@yandex.ru.
⁶ Department of Health Sciences, Genoa University, Genoa, Italy. Electronic address: gasparini@unige.it.
⁷ Department of Epidemiology, Medical Faculty Pilsen of Charles University, Czech Republic. Electronic address: PAZDIORA@fnplzen.cz.
⁸ Pediatrics, University of Medicine and Pharmacy, Bucharest, Romania. Electronic address: doinaplesca@yahoo.com.
⁹ Servizio di Igiene Pubblica, ASL Sassari, Italy. Electronic address: madesole@aslsassari.it.
¹⁰ Pediatric Clinic, Lithuanian University of Health Sciences, Kaunas, Lithuania. Electronic address: rimantas.kevalas@kaunoklinikos.lt.
¹¹ Department of Medical Sciences, University of Ferrara, Ferrara, Italy. Electronic address: giovanni.gabutti@unife.it.
¹² Biostatistics, GSK, Wavre, Belgium. Electronic address: michael.x.povey@gsk.com.
¹³ Vaccine Discovery and Development, GSK, Philadelphia, United States. Electronic address: innisb00@gmail.com.

PMID: 30244871
DOI: 10.1016/j.vaccine.2018.09.022

Free article

Published Erratum

Corrigendum to "One or two doses of live varicella virus-containing vaccines: Efficacy, persistence of immune responses, and safety six years after administration in healthy children during their second year of life" [Vaccine 36 (2018) 381-387]

Ouzama Henry et al. Vaccine. 2018.

Free article

. 2018 Oct 29;36(45):6894.

doi: 10.1016/j.vaccine.2018.09.022. Epub 2018 Sep 21.

Authors

Affiliations

¹ Vaccine Discovery and Development, GSK, Philadelphia, United States. Electronic address: ouzama.n.henry@gsk.com.
² Poradnia Chorób Zakaźnych ZOZ Dębica, Dębica, Poland. Electronic address: jerzy_br@poczta.onet.pl.
³ Infectious Diseases Outpatient Clinic, The St. Luis Provincial Specialist Children's Hospital, Cracow, Poland. Electronic address: hanna.czajka@onet.pl.
⁴ Pediatric Clinic, Lithuanian University of Health Sciences, Kaunas, Lithuania. Electronic address: giedralev@gmail.com.
⁵ Pharmacology, Saratov Medical University, Saratov, Russia. Electronic address: reshetko@yandex.ru.
⁶ Department of Health Sciences, Genoa University, Genoa, Italy. Electronic address: gasparini@unige.it.
⁷ Department of Epidemiology, Medical Faculty Pilsen of Charles University, Czech Republic. Electronic address: PAZDIORA@fnplzen.cz.
⁸ Pediatrics, University of Medicine and Pharmacy, Bucharest, Romania. Electronic address: doinaplesca@yahoo.com.
⁹ Servizio di Igiene Pubblica, ASL Sassari, Italy. Electronic address: madesole@aslsassari.it.
¹⁰ Pediatric Clinic, Lithuanian University of Health Sciences, Kaunas, Lithuania. Electronic address: rimantas.kevalas@kaunoklinikos.lt.
¹¹ Department of Medical Sciences, University of Ferrara, Ferrara, Italy. Electronic address: giovanni.gabutti@unife.it.
¹² Biostatistics, GSK, Wavre, Belgium. Electronic address: michael.x.povey@gsk.com.
¹³ Vaccine Discovery and Development, GSK, Philadelphia, United States. Electronic address: innisb00@gmail.com.

PMID: 30244871
DOI: 10.1016/j.vaccine.2018.09.022

No abstract available

PubMed Disclaimer

Erratum for

One or two doses of live varicella virus-containing vaccines: Efficacy, persistence of immune responses, and safety six years after administration in healthy children during their second year of life.
Henry O, Brzostek J, Czajka H, Leviniene G, Reshetko O, Gasparini R, Pazdiora P, Plesca D, Desole MG, Kevalas R, Gabutti G, Povey M, Innis B. Henry O, et al. Vaccine. 2018 Jan 8;36(3):381-387. doi: 10.1016/j.vaccine.2017.11.081. Epub 2017 Dec 7. Vaccine. 2018. PMID: 29224964 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Corrigendum to "One or two doses of live varicella virus-containing vaccines: Efficacy, persistence of immune responses, and safety six years after administration in healthy children during their second year of life" [Vaccine 36 (2018) 381-387]

Affiliations

Corrigendum to "One or two doses of live varicella virus-containing vaccines: Efficacy, persistence of immune responses, and safety six years after administration in healthy children during their second year of life" [Vaccine 36 (2018) 381-387]

Authors

Affiliations

Erratum for

Publication types

LinkOut - more resources

Full Text Sources

Other Literature Sources